UNC Has Key Role in COVID-19 Drug Nearly Ready for Human Trials
Posted Apr 8, 2020
Scientists in Ralph Baric’s lab at UNC are playing a key role in the development and testing of a new drug, called EIDD-2801, that could change the way doctors treat COVID-19. The drug shows promise in reducing lung damage, has finished testing in mice and will soon move to human clinical trials. Baric is UNC’s Kenan Distinguished Professor of epidemiology.
(Carolina Alumni Review)
Related: Campus Connections
Longest-running fraternity at UNC shut down by national boardThe longest-running fraternity at UNC-Chapel Hill has been shut down by its national office, university officials said Thursday. The UNC chapter of Alpha Tau Omega...
Fri Jun 20, 2025UNC Alumnus Killed in Minnesota Assassination
Mark Hortman, the husband of slain Minnesota lawmaker Melissa Hortman, was killed alongside his wife in a targeted attack at their home Saturday. Mark Hortman,...
Fri Jun 20, 2025
36 Hours in Chapel Hill: A Perfect Weekend Itinerary of Food, Fun & Local Charm
We’ve explored just about every corner of the Triangle, but Chapel Hill always gives us new reasons to fall in love. With its perfect blend...
Wed Jun 18, 2025
Chapel Hill's Siena Hotel Leadership Recaps Busy Week Hosting Mexico Men’s National Team
The Mexico men’s soccer national team earned a 1-0 win over Türkiye on Tuesday at Kenan Stadium, part of the team’s ongoing MEXTOUR ahead of...
Tue Jun 17, 2025